Bursts and the efficacy of selective serotonin reuptake inhibitors

Pharmacopsychiatry

Volumn 44, Issue SUPPL. 1, 2011, Pages

  Best, J ^a   Nijhout, H F ^b   Reed, M ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PAROXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRYPTOPHAN HYDROXYLASE;

ACTION POTENTIAL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG EFFICACY; GENETIC POLYMORPHISM; HIPPOCAMPAL CA3 REGION; HUMAN; MATHEMATICAL MODEL; MEDIAN RAPHE NUCLEUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL;

ANIMALS; ANTIDEPRESSIVE AGENTS; EXTRACELLULAR SPACE; HUMANS; MODELS, THEORETICAL; NEURONS; RAPHE NUCLEI; RATS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 79955810979     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1273697     Document Type: Article

References (66)

1. Adell A, Celada P, Abella MT et al,. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Rev 2002 39 154-180 (Pubitemid 35341097)
2. Anderson GM, Barr CS, Lindell S et al,. Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey. Phycopharma 2005 178 339-346 (Pubitemid 40379229)
3. Baghai TC, Möller HJ, Rupprecht R. Recent progress in pharmacological and nonpharmacological treatment options of major depression. Curr Pharm Design 2006 12 503-515
4. Bel N, Artigas F. Fluoxetine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 1992 229 101-103
5. Bengel D, Murphy DL, Andrews AM et al,. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (ecstasy) in serotonin transporter-deficient mice. Amer Soc Pharma Exper Therap 1998 53 649-655 (Pubitemid 28196486)
6. Benkelfat C, Ellenbogen MA, Dean P et al,. Mood-lowering effect of tryptophan depletion. Arch Gen Psych 1994 51 687-697
7. Benmansour S, Owens WA, Cecchi M et al,. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of the transporter. J Neurosci 2002 22 no. 15 6766-6772 (Pubitemid 35386433)
8. Best JA, Nijhout HF, Reed MC. Serotonin synthesis, release and reuptake in terminals: a mathematical model. Theor Biol Med Model 2010 7 34
9. Birzniece V, Johansson I-M, Wang M-D et al,. Serotonin 5-HT1a receptor mRNA expression in dorsal hippocampus and raphe nuclei after gonadal hormone manipulation in female rats. Neuroendocrinology 2001 74 no. 2 135-142 (Pubitemid 32727580)
10. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatment: implications for the therapeutic response in major depression. J Clin Psychoharmacol 1987 7 24S-35S (Pubitemid 18014273)
11. Bunin MA, Prioleau C, Mailman RB et al,. Release and uptake rates of 5-hydroxytryptamine in the dorsal raphe and substantia nigra of the rat brain. J Neurochem 1998 70 1077-1087 (Pubitemid 28113641)
12. Casanovas JM, Artigas F. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. J Neurochem 1996 67 1945-1952 (Pubitemid 26349667)
13. Casanovas JM, Lesourd M, Artigas F. The effect of the selective 5-HT1a agonists alnespirone (s-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Brit J Pharmacol 1997 122 733-741 (Pubitemid 27453100)
14. Celada P, Puig MV, Casanovas JM et al,. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABAa, and glutamate receptors. J Neurosci 2001 15 9917-9929 (Pubitemid 34184076)
15. Chaput Y, Blier P, de Montigny C. In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 1986 6 no. 10 2796-2801 (Pubitemid 16026058)
16. Conley RK, Cumberbatch MJ, Mason GS et al,. Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 2002 22 7730-7736 (Pubitemid 35390361)
17. Daws LC, Montenez S, Owens WA et al,. Transport mechanisms governing serotonin clearance in vivo revealed by high speed chronoamperometry. J Neurosci Meth 2005 143 49-62 (Pubitemid 40348789)
18. Feldman RS, Meyer JS, Quenzer LF. Principles of Neuropharmacology. Sinauer Associates, Inc, Sunderland, MA 1997
19. Fite KV, Janusonis S, Foote W et al,. Retinal afferents to the dorsal raphe nucleaus in rats and mongolian gerbils. J Comp Neurol 1999 414 469-484 (Pubitemid 29506360)
20. Fornal CA, Litto WJ, Metzler CW et al,. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1a agonist and antagonist drug administration in behaving cats. J Pharmacol Exper Therap 1994 270 1345-1358 (Pubitemid 24315260)
21. Gartside SE, Umbers V, Hajos M et al,. Interaction between a selective 5-HT1a receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 1995 115 1064-1070
22. Georgetti M, Tecott LH. Contributions of 5-HT2c receptors to multiple actions of central serotonin systems. Eur J Pharmacol 2004 488 1-9 (Pubitemid 38388517)
23. Gould GG, Pardon MC, Morilak DA et al,. Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems. Neuropsychopharmacology 2003 28 1633-1644
24. Hajos M, Allers KA, Jennings K et al,. Neurochemical identification of stereotypic burst-firing neurons in the rat dorsal raphe nucleus using juxtacellular labelling methods. Eur J Neurosci 2007 25 119-126 (Pubitemid 46096228)
25. Hajos M, Gartside SE, Villa AEP et al,. Evidence for a repetitive (burst) firing pattern in a sub-population of 5-hydroxytryptamine neurons in the dorsal and median raphe nuclei of the rat. Neuroscience 1995 69 189-197
26. Hajos M, Sharp T. Burst-firing activity of presumed 5-ht neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res 1996 740 162-168 (Pubitemid 26411295)
27. Heisler LK, Pronchuk N, Nonogaki K et al,. Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2c receptor stimulation. J Neurosci 2007 27 no. 26 6956-6964 (Pubitemid 47015900)
28. Hervas I, Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5HT autoreceptors. Eur J Pharmacol 1998 358 9-18 (Pubitemid 28464463)
29. Hervas I, Velaro MT, Romero L et al,. Desensitization of 5-HT1a autoreceptors by a low chronic fluoxetine dose. Effect of the concurrent administration of WAY-100635. Neuropsychopharmacology 2001 24 11-20
30. Heyn J, Steinfels GF, Jacobs BJ. Activity of serotonin-containing neurons in the nucleus raphe pallidus of freely moving cats. Brain Res 1982 251 259-276 (Pubitemid 13230301)
31. Homberg JR, Olivier JDA, Smits BMG et al,. Characterization of the serotonin transporter knock out rat: a selective change in the functioning of the serotonergic system. Neurosci 2007 146 1662-1676 (Pubitemid 46783222)
32. Invernizzi R, Bramante M, Samanin R. Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 1992 260 322-324
33. Izhikevich EM. Dynamical systems in neuroscience: The geometry of excitability and bursting. MIT Press, Cambridge, MA 2007
34. Jacobs BL, Fornal CA. 5-HT and motor control: a hypothesis. TINS 1993 16 346-352 (Pubitemid 23232006)
35. Knobelman DA, Hen R, Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxtryptamine-1a and 5-hydroxytryptamine-1b autoreceptors in different brain regions of the mouse. J Pharmacol Exper Therap 2001 298 1083-1091 (Pubitemid 32761924)
36. Kranz GS, Kasper S, Lanzenberger R. Reward and the serotonergic system. Neuroscience 2010 166 no. 4 1023-1035
37. Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-HT measured in vivo. J Pharmacol Exper Therap 1995 274 866-876
38. Lau T, Horschitz S, Berger S et al,. Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons. FASEB J 2008 22 1702-1714 (Pubitemid 351811448)
39. Levine ES, Jacobs B. Neurochemical afferents controlling the activity of serotonergic neurons in the dorsal raphe nucleus: Microiontophoretic studies in the awake cat. J Neurosci 1992 12 no. 4037-4044
40. Lin K-J, Yen T-C, Wey S-P et al,. Characterization of the binding sites 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography. J Nuc Med 2004 45 673-681 (Pubitemid 47618599)
41. Malagie I, Trillat AC, Bourin M et al,. 5-HT1b autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex. J. Neurochem 2001 76 865-871 (Pubitemid 32126086)
42. Malagie I, Trillat AC, Jacquot C et al,. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur J Pharmacol 1995 286 213-217
43. Maley BE, Engle MG, Humphreys S et al,. Monoamine synaptic structure and localization in the central nervous system. J Electron Micros Tech 1990 15 20-33 (Pubitemid 20138662)
44. Marek GJ, Aghajanian GK. The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biolog Psychiatry 1998 44 no. 11 1118-1127 (Pubitemid 28547146)
45. Mascio MD, Giovanni GD, Matteo VD et al,. Decreased chaos of midbrain dopaminergic neurons after serotonin denervation. Neuroscience 1999 92 no. 1 237-243
46. Mizra NR, Nielson EO, Troelsen KB. Serotonin transporter density and anxiolytic-like effects of antidepressants in mice. Prog Neuropsycho Biol Psych 2007 31 858-866 (Pubitemid 46660292)
47. Morris C, Lecar H. Voltage oscillations in the barnacle giant muscle fiber. Biophys J 1981 35 193-213 (Pubitemid 11079105)
48. Parnavelas JG, Papadopoulos GC. The monoaminergic innervation of the cerebral cortex is not diffuse and non-specific. TINS 1989 12 315-319 (Pubitemid 19207613)
49. Peyron C, Petit J-M, Rampon C et al,. Forebrain afferents to the rat dorsal raphe nucleus demonstrated by retrograde and anterograde tracing methods. Neurosci 1997 82 443-468
50. Ranade SP, Mainen ZF. Transient firing of dorsal raphe neurons encodes diverse and specific sensory, motor, and reward events. J Neurophysiol 2009 102 3026-3037
51. Rinzel J, Ermentrout B. Methods in Neuronal Modeling: from Ions to Networks, ch. 7. MIT press 1998
52. Ruh HG, Huyser J, Swinkeis JA et al,. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry 2006 67 1836-1855 (Pubitemid 46055194)
53. Rutter JJ, Gundlah C, Auerbach SB. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Lett 1994 171 183-186 (Pubitemid 24142120)
54. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Amer J Psych 1965 122 509-522
55. Schweimer JV, Ungless MA. Phasic responses in dorsal raphe serotonin neurons to noxious stimuli. Neuroscience 2010 171 1209-1215
56. Smith T, Kuczenski R, George-Friedman K et al,. In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration. Synapse 2000 38 460-470
57. Stancampiano R, Melis F, Sarais L et al,. Acute administration of a tryptophan-free amino acid mixture decreases 5-HT release in rat hippocampus in vivo. Am J Physiol 1997 272 R991-R994
58. Stein P, Savli M, Wadsakj W et al,. The serotonin-1a receptor distribution in healthy men and women measured by pet and [carbonyl- 11c]WAY-100635. Eur J Nucl Med 2008 35 no. 12 2159-2168
59. Strogatz SH. Nonlinear Dynamics and Chaos. Addison-Wesley, Reading, MA 1994
60. Tanda G, Frau R, Di Chiara G. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat pre-frontal cortex. Psychopharmacology 1996 127 83-87 (Pubitemid 26298003)
61. Vesly SC, Fornal CA, Metzler CW et al,. Single-unit responses of serotonergic dorsal raphe neurons to specific motor challenges in freely moving cats. Neuroscience 1997 79 161-169 (Pubitemid 27245007)
62. Weissmann-nanopoulos D, Mach E, Magre J et al,. Evidence for the localization of 5HT1a binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 1985 7 1061-1072 (Pubitemid 16185105)
63. White KJ, Walline CC, Barker EL. Serotonin transporters: implications for antidepressant drug development. AAPS J 2005 7 E421-E433
64. Williams S, Bryan-Lluka LJ, Pow DV. Quantitative analysis of immunolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram. Brain Res 2005 1042 224-232 (Pubitemid 40591732)
65. Young SN, Smith SE, Pihl R et al,. Tryptophan depletion causes rapid lowering of mood in normal males. Psychopharmacology 1985 87 173-177 (Pubitemid 16253342)
66. Zusso M, Debetto P, Guidolin D et al,. Fluoxetine-induced proliferation and differentiation of neural progenitor cells isolated from rat postnatal cerebellum. Biochemical Pharmacology 2008 76 391-403